Skip to content
    SLF
    Earnings call· Jun 2025(Q2 FY25)

    SUN LIFE FINANCIAL INC SLF

    Aug 8, 2025 Source

    Executive summary

    Sun Life Financial Q2 FY25 — Strong Underlying Earnings and Capital Position

    Sun Life Financial delivered solid Q2 FY25 results, driven by strong underlying earnings and robust capital. While the U.S. Dental business faces near-term headwinds from Medicaid funding uncertainty, the company maintains its medium-term growth objectives and strategic focus on asset management, Asia expansion, and digital innovation. Leadership changes were announced to ensure smooth transitions in key U.S. and actuarial roles.

    Highlights

    5

    • Underlying EPS was $1.79, up 4% year-over-year.

    • Underlying net income was strong at just over $1 billion.

    • Underlying ROE was 17.6%.

    • SLC Management capital raising was $6 billion, doubling over last year.

    • Asia CSM was up 23% year-over-year, ending the quarter at $6.2 billion.

    Concerns

    3

    • U.S. Dental business no longer expects to achieve USD 100 million in earnings this year due to Medicaid funding uncertainty and repricing delays.

    • MFS experienced net outflows of USD 14.3 billion, including retail outflows of $5.9 billion and institutional outflows of $8.4 billion.

    • An impairment charge of USD 61 million was recorded on a customer relationship intangible related to the early termination of a U.S. group Dental contract.

    Guidance & targets

    9
    CategoryTargetConfidence
    U.S. Dental Business Earnings
    No longer expect to achieve USD 100 million
    high materiality
    Medium
    U.S. Business Segment Underlying Earnings Growth
    12% plus
    high materiality
    High
    Dental Contribution to U.S. Earnings Growth
    At least 1/3
    medium materiality
    High
    SLC Management Earnings
    $235 million
    high materiality
    High
    SLC Management Underlying Earnings Growth
    20% growth
    high materiality
    High
    SLC Management FRE Growth
    20% FRE growth
    high materiality
    High
    U.S. Dental Repricing
    Rates back to full expected margins
    high materiality
    Medium
    Corporate Segment Expenses
    Roughly $100 million
    low materiality
    Medium
    Total Cost Efficiencies
    $200 million
    medium materiality
    High

    Segment performance

    5
    SegmentRevenueYoYQoQMargin
    MFS
    Underlying net income decreased primarily due to lower fee income from lower average net assets. Pretax operating net margin declined due to lower fee income and interest income. AUM increased sequentially due to market appreciation, partially offset by net outflows driven by market uncertainty and client rebalancing.
    Pretax operating net margin: 35.1%Pretax operating net margin change YoY: -1.4 percentage pointsAssets under management: USD 635 billionAUM growth YoY: 3%AUM growth QoQ: 5%Net outflows: USD 14.3 billionRetail outflows: USD 5.9 billionInstitutional outflows: USD 8.4 billionFund assets ranked in top half (10-year performance): 90%Fixed income fund assets ranked in top half (10-year performance): 98%
    		—-5%—USD 184 million (Underlying Net Income)
    SLC Management
    Underlying net income increased year-over-year but declined sequentially from a record prior quarter due to catch-up fees and seed investment gains. Fee-related earnings saw strong growth driven by capital raising and lower expenses. Fee-earning AUM was down sequentially due to currency impacts.
    Fee-related earnings: $89 millionFee-related earnings growth YoY: 37%Reported net income: $0Capital raising: $6 billionDeployments: $6 billionFee-earning AUM: $194 billionFee-earning AUM growth YoY: 9%Fee-earning AUM growth QoQ: -4%
    		—7%—$45 million (Underlying Net Income)
    Canada
    Underlying net income decreased due to lower investment results and less favorable insurance experience, despite strong business growth. Reported net income increased due to more favorable market-related impacts. Group sales were strong, driven by large case wins, while Individual Protection sales declined.
    Underlying Net Income growth YoY: -6%Reported Net Income: $330 millionReported Net Income growth YoY: 13%Asset Management and Wealth underlying earnings growth YoY: -4%Wealth AUM: $203 billionWealth AUM growth YoY: 12%Group Health and Protection underlying earnings growth YoY: 1%Group sales growth YoY: 41%Individual Protection earnings growth YoY: -16%Individual Protection sales growth YoY: -19%
    		———$379 million (Underlying Net Income)
    Sun Life U.S.
    Underlying net income decreased year-over-year. Group Health and Protection earnings increased due to business growth in Employee Benefits and Dental, partially offset by unfavorable experience. Sales were down due to pricing discipline in medical stop-loss. Individual Protection earnings declined due to unfavorable mortality and credit impairments.
    Group Health and Protection underlying earnings growth YoY: 10%Group Health and Protection underlying earnings: USD 121 millionGroup Health and Protection underlying earnings prior year: USD 124 millionU.S. Group Health and Protection sales: USD 226 millionU.S. Group Health and Protection sales growth YoY: -7%Individual Protection underlying earnings growth YoY: -46%Reported Net Income: USD 74 millionReported Net Income growth YoY: -19%
    		—-4%—USD 143 million (Underlying Net Income)
    Asia
    Asia posted record underlying net income, driven by strong business growth in Individual Protection and higher fee income in Asset Management and Wealth. Individual Protection sales were strong, particularly in Hong Kong and Indonesia. Total CSM and new business CSM showed significant growth.
    Individual Protection earnings growth YoY: 7%Asset Management and Wealth earnings growth YoY: 67%Reported Net Income: $98 millionIndividual Protection sales growth YoY: 22%Total CSM: $6.2 billionTotal CSM growth YoY: 23%New business CSM: $299 millionNew business CSM growth YoY: 34%India Asset Management JV net wealth sales: nearly doubledIndia Asset Management JV wealth assets growth YoY: 21%Hong Kong protection sales growth: 35%Bancassurance distribution sales growth YoY: 14%
    		—13%—$206 million (Underlying Net Income)

    Operational metrics

    35
    Underlying EPS
    $1.79up 4% year-over-year
    Q2 FY25

    Reflects solid results across all businesses.

    Underlying Net Income
    $1.015 billionup 2% year-over-year
    Q2 FY25

    Strong results across the diversified business model.

    Underlying ROE
    17.6%down from the prior year
    Q2 FY25

    Impacted by higher average equity from earnings growth and changes to other comprehensive income.

    LICAT ratio
    151%up 2 points from the prior quarter
    Q2 FY25

    Reflects strong capital position, with organic capital generation offsetting dividends, share buybacks, and markets.

    Holdco cash
    $1.1 billion
    Q2 FY25

    Remains solid after returning almost $1 billion to shareholders.

    Leverage ratio
    20.4%
    Q2 FY25

    Remains low.

    Book value per share growth
    5%over the prior year
    Q2 FY25

    Demonstrates ability to generate strong growth while returning value to shareholders.

    Shares repurchased
    4.8 million
    Q2 FY25

    Repurchased under the share buyback program.

    Share buyback amount
    close to $400 million
    Q2 FY25

    Executed through the share buyback program.

    Total contractual service margin (CSM)
    $13.7 billionincreased 9% year-over-year
    Q2 FY25

    Reflects future profits, driven by strong organic CSM growth.

    New business CSM
    $435 millionflat compared to the prior year
    Q2 FY25

    Represents future profits from new business.

    Organic capital generation (net of dividends)
    $673 millionabove our target range of 30% to 40% of underlying net income
    Q2 FY25

    Strong capital generation.

    MFS Average Net Assets
    USD 608 billiondown from USD 620 billion in Q2 FY24
    Q2 FY25

    The decline in average net assets was the primary driver for the year-on-year margin decrease.

    SLC Management seed investment loss
    modest
    Q2 FY25

    Contributed to the below-trend underlying net income result for the quarter.

    SLC Management catch-up fees
    $0
    Q2 FY25

    Contributed to the volatility in underlying net income compared to the prior quarter which had higher catch-up fees.

    Canada Wealth AUM
    $203 billionup 12% year-over-year
    Q2 FY25

    Driven by market appreciation and net inflows.

    U.S. Dental Medicaid membership (kids)
    80%
    Current

    Indicates the demographic composition of the Medicaid membership, largely unaffected by adult coverage changes in the reconciliation bill.

    U.S. Dental Medicaid membership loss (PHE end)
    19.5%
    Early 2023 to Mid-2024

    Loss of membership following the end of the public health emergency.

    U.S. Dental premium and fees loss (PHE end)
    $400 million
    Early 2023 to Mid-2024

    Represents the impact on revenue from membership losses after the public health emergency ended.

    U.S. Dental business growth since DentaQuest acquisition
    $200 million
    Since acquisition

    Despite membership losses post-PHE, the overall Dental business has grown since acquisition due to new sales.

    U.S. Dental new members
    6 million
    June 1, 2025 - January 1, 2026

    New business coming on board, mostly Medicaid, some Medicare Advantage and commercial.

    U.S. Dental commercial business mix
    less than 20%
    Current

    Management aims to significantly increase this proportion in the future.

    U.S. Dental rate increases (last year)
    $140 million
    Last year

    Achieved in rate increases, though this year's increases are expected to be less.

    MPF business quarterly impact
    CAD 10 million
    Per quarter

    Impact from the Monetary Provident Fund Scheme Authority taking over administrative capabilities, reducing fees earned.

    Other fee income
    up $18 millionyear-on-year
    Q2 FY25

    Includes administrative services-only fees, wealth businesses in Canada and Asia, and care delivery services in the U.S. Elevated this quarter due to strong asset and wealth management growth.

    Total operating expenses
    $440 milliondown $10 million from Q2 FY24, down $50 million quarter-over-quarter
    Q2 FY25

    Favorable results, mostly from the corporate segment, driven by timing of initiative spend and incentive compensation.

    Corporate segment expenses
    $110 million
    Q2 FY25

    Reflects favorable timing and incentive compensation, but expected to normalize around $100 million per quarter.

    Cost efficiencies (Q2 FY25)
    $25 million
    Q2 FY25

    Savings achieved in the quarter as part of the overall expense efficiency program.

    Total cost efficiencies (to date)
    66%
    To date

    Progress towards the overall $200 million cost efficiency target by the end of 2026.

    U.S. Dental impairment charge
    USD 61 million
    Q2 FY25

    Impairment charge on a customer relationship intangible related to the early termination of a U.S. group Dental contract.

    U.S. Dental customer relationships and system intangibles (acquisition)
    $1.2 billion
    At acquisition

    Amount set up at the time of the DentaQuest acquisition.

    U.S. Dental goodwill (acquisition)
    $2 billion
    At acquisition

    Amount of goodwill on the books at the time of the DentaQuest acquisition.

    Stop-loss 1/1/24 cohort adverse experience reversal
    1/3
    Q1-Q2 FY25

    Reversal of the significant spike in medical expenses seen in Q4 FY24 for the 1/1/24 cohort.

    Stop-loss 1/1/25 cohort claims received
    12%
    Q2 FY25

    Percentage of claims received for the 1/1/25 cohort, indicating early experience.

    Stop-loss 1/1/25 cohort pricing shortfall
    2%
    FY25

    Anticipated pricing shortfall for the 2025 cohort, which has since been addressed with price increases.

    Industry KPIs

    5
    MetricValueDetails
    Capital returns$400 millionCAD
    ROE operating ROE17.6%%
    Book value per share—
    Net investment income—
    Statutory regulatory capital151%%

    Product announcements

    6
    ProductTypeDetails
    Index Universal Life Insurance Productlaunch
    Reimagined Mobile Applicationlaunch
    Adviser Notes Assistantlaunch
    Real-time Underwriting Capabilitiesupdate
    Adviser Buddylaunch
    Straight-through Processing for Supplemental Health Accident Insuranceupdate

    Deals & partnerships

    1
    BowtieFurther investment in a digital company that helps with insurance for clients in Hong Kong, complementing Sun Life's distribution force.

    Sun Life announced a further investment in Bowtie, a digital company recognized as the fastest-growing company in Hong Kong. Sun Life has partnered with Bowtie since its inception, leveraging its direct-to-consumer model.

    Risks & headwinds

    4
    U.S. Dental Medicaid Funding UncertaintyNear-term (through 2026)

    U.S. Dental business no longer expected to achieve USD 100 million in earnings this year; repricing expected to take through 2026.

    Mitigation: Re-forecasting earnings trajectory, focusing on commercial growth, optimizing Medicaid/Medicare space, and continued efforts on repricing.

    MFS OutflowsQ2 FY25

    USD 14.3 billion net outflows (retail $5.9 billion, institutional $8.4 billion).

    Mitigation: Strong total gross sales, momentum in active ETFs and fixed income, focus on long-term investment performance.

    U.S. Dental Contract Termination & ImpairmentQ2 FY25

    USD 61 million impairment charge on a customer relationship intangible.

    Mitigation: The termination was a unique situation (related party to seller), not indicative of broader issues; overall goodwill remains strong.

    U.S. Dental Increased Utilization/SeverityQ2 FY25 and ongoing

    Elevated Dental loss ratios due to higher per-member utilization and severity in Medicaid claims.

    Mitigation: Upping game on handling billing practices, ensuring future pricing reflects this dynamic, especially with provider billing practices aided by AI.

    What to watch in Q3 FY25

    5

    U.S. Dental repricing progress

    Next quarter (Q3 FY25) and through 2026
    CurrentRepricing slowed by Medicaid funding uncertainty.
    TargetAccelerated repricing actions, improved margins.

    Why it matters

    Critical for the recovery of the U.S. Dental business profitability and achieving the 12%+ U.S. segment earnings growth objective.

    We anticipate that it likely will take through 2026 to get the rates back to full expected margins.

    Q&A highlights

    7

    What is the updated outlook for the U.S. Dental business, specifically regarding the $250 million 2029 target and its contribution to U.S. earnings growth? Are there concerns about goodwill or intangible write-offs given the current challenges?

    Management is reforecasting the near-term earnings outlook for U.S. Dental due to uncertainties but remains committed to the overall U.S. segment's 12%+ medium-term earnings growth, with Dental expected to contribute at least one-third. While a specific customer intangible was written off (USD 61 million), overall goodwill is considered robust due to the long-term outlook and regular impairment testing.

    “we're committed to the 12% plus objective that we shared at Investor Day. And as mentioned, expect that Dental will be at least 1/3 of that overall earnings growth for the segment.”

    asked by Doug Young · answered by Timothy Deacon

    2 min read6 chapters

    Detailed Narrative

    01

    U.S. Dental Business Challenges

    The U.S. Dental business is facing near-term challenges due to uncertainty around Medicaid funding and slower repricing actions, contributing to elevated loss ratios. Management is reforecasting expected earnings trajectory for the business, though it remains confident in the long-term outlook and its strategic importance. The business saw a USD 61 million impairment charge related to a specific contract termination, but overall goodwill is considered strong due to long-term prospects and regular impairment testing. Commercial Dental business, currently less than 20% of the mix, is a key growth area.

    02

    Leadership Transitions

    Kevin Strain announced the retirement of Dan Fishbein, President of Sun Life U.S., in March 2026, with David Healy taking over as President on September 1, 2025. Kevin Morrissey, Chief Actuary, will also retire this fall, succeeded by Brennan Kennedy. These transitions are designed to ensure continuity and leverage internal talent, with both new leaders bringing extensive experience to their roles.

    03

    Digital and AI Advancements

    Sun Life made substantial progress in digital leadership, deploying new generative AI capabilities to enhance client experience and operational productivity. Key initiatives include a reimagined mobile app and Adviser Notes Assistant in Canada, real-time underwriting capabilities in Malaysia, and an AI chatbot pilot (Adviser Buddy) in Hong Kong. In the U.S., straight-through processing for supplemental health accident insurance was implemented to improve productivity.

    04

    MFS Performance and Strategy

    MFS experienced net outflows of USD 14.3 billion, primarily from retail and institutional rebalancing, but saw strong total gross sales, which are up year-over-year. The business continues to build momentum in active ETFs and fixed income, with 90% of fund assets ranked in the top half of Morningstar for 10-year performance. Management emphasizes MFS's strategic role, solid margins, and cash flow, focusing on long-term performance despite market volatility🌐.

    05

    SLC Management Growth

    SLC Management reported strong capital raising of $6 billion this quarter, doubling over last year, and fee-related earnings up 37% year-over-year. Despite a modest seed investment loss and zero catch-up📎 fees this quarter, the business is on track for its Investor Day earnings targets of $235 million for FY25 and 20% underlying earnings and FRE growth over the medium term⏳, driven by deployments and market appreciation.

    06

    Asia Momentum

    Asia delivered record underlying net income of $206 million, up 13% year-over-year, with strong sales in Individual Protection (up 22% YoY) and Asset Management and Wealth earnings growing 67%. Growth was particularly robust in Hong Kong across all channels, and in India's Asset Management joint venture, which saw net wealth sales nearly double and wealth assets grow 21% year-over-year.

    AI-generated summary of the company’s earnings call. Not investment advice.